Seneca Financial Advisors LLC Athenex, Inc. Transaction History

Seneca Financial Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Aug 27, 2025	SELL	$0.17 - $3.42 $23,374 - $470,232	-137,495 Closed	0 $0
Q1 2022 Aug 27, 2025	BUY	$0.79 - $1.59 $19,035 - $38,312	24,096 Added 21.25%	137,495 $114 Million
Q4 2021 Aug 27, 2025	SELL	$1.36 - $2.94 $32,770 - $70,842	-24,096 Reduced 17.53%	113,399 $154 Million
Q1 2021 Aug 27, 2025	BUY	$4.08 - $14.75 $102,563 - $370,785	25,138 Added 22.37%	137,495 $591 Million
Q4 2020 Aug 27, 2025	BUY	$11.06 - $14.01 $1.24 Million - $1.57 Million	112,357 New	112,357 $1.24 Billion

1.46M

Ticker ATNX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 156,790,000
Market Cap $1.57M
Description
Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral paclitaxel and encequidar,...

Get notified when there are updates to the investment portfolio of Seneca Financial Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Seneca Financial Advisors LLC with notifications on news.